Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • mrfox
    Senior Member
    • Aug 2010
    • 103

    #1

    large variance of raw read numbers between samples

    Hi all,

    My collaborators used Illumina HiSeq to sequence 5 samples (RNA-Seq). I am not sure how many lanes they used but the 5 samples were barcoded and sequenced with multiplexing. The 5 samples include 2 replicates for one condition and 3 replicates for the other. The read length is 50, single end. The samples were prepared and sequenced under the same condition. So I expect that we will obtain similar number of raw reads for the 5 samples.

    However, I got 5.5G, 5.7G, 8.6G, 9.1G and 12G respectively for the 5 FASTQ files, reflecting the large variance of raw read numbers. Since the sequencing core would not provide quality control report or the detailed sequencing protocol, so I am not sure if this variance resulted from potential bias in some step of the sequencing experiment.

    I wonder if anybody could tell if the observed read number variance is normal or it does reflect some bias.

    THank you very much.
  • mrfox
    Senior Member
    • Aug 2010
    • 103

    #2
    Any advice? Thanks.

    Comment

    • dpryan
      Devon Ryan
      • Jul 2011
      • 3478

      #3
      You could look through the fastq files and likely determine how many lanes were used. They may also still contain the barcode information, so you could see how that was done. I've gotten a lot of variance in read numbers before in data returned from our various sequencing providers, usually having to do with the quality of the library before loading.

      Comment

      • kopi-o
        Senior Member
        • Feb 2008
        • 319

        #4
        It looks completely normal to me (we do a lot of multiplexed RNA-seq at our facility)

        Comment

        • jgibbons1
          Senior Member
          • Oct 2009
          • 135

          #5
          I'd say it looks pretty normal to me too. Obviously it's nice to have all samples in a tighter range, but it is pretty difficult to do so even with multiple modes of quantification. I recently multiplexed 8 samples, and quantified them with bioanalyzer, qubit and qPCR and still had a range of 25 million - 50 million reads per sample.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          10 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          11 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          23 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          37 views
          0 reactions
          Last Post SEQadmin2  
          Working...